Standout Papers
Citation Impact
Citing Papers
Rhizobium induces DNA damage in Caenorhabditis elegans intestinal cells
2019 StandoutNobel
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
Portal hypertension and the outcome of surgery for hepatocellular carcinoma in compensated cirrhosis: A systematic review and meta‐analysis
2014
Intrahepatic Peripheral Cholangiocarcinoma in Cirrhosis Patients May Display A Vascular Pattern Similar to Hepatocellular Carcinoma on Contrast-Enhanced Ultrasound
2010
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
mRECIST for HCC: Performance and novel refinements
2020
Nitric Oxide Production and Nitric Oxide Synthase Type 2 Expression by Human Mononuclear Phagocytes: A Review
1998
Non-invasive diagnosis of hepatocellular carcinoma ⩽2cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
2012
Inflammation and Alzheimer's disease
2000 Standout
Evaluation of tumor response after locoregional therapies in hepatocellular carcinoma
2008
Hepatocellular carcinoma
2003 Standout
From NASH to HCC: current concepts and future challenges
2019
Nonalcoholic Fatty Liver Disease: From Steatosis to Cirrhosis
2006 Standout
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
2014
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Surveillance for Hepatocellular Carcinoma and Early Diagnosis
2007
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
TP53 and gastric carcinoma: A review
2003
Redox biology and gastric carcinogenesis: the role ofHelicobacter pylori
2011
Helicobacter pylori infection triggers aberrant expression of activation-induced cytidine deaminase in gastric epithelium
2007 StandoutNobel
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Retreatment with TACE: The ABCR SCORE, an aid to the decision-making process
2014
Focus on hepatocellular carcinoma
2004
Characterization of Small Nodules in Cirrhosis by Assessment of Vascularity: The Problem of Hypovascular Hepatocellular Carcinoma *
2005
Lethal Mutagenesis of Hepatitis C Virus Induced by Favipiravir
2016 StandoutNobel
Is tumor biopsy necessary?
2011
Combined p53/Bax mutation results in extremely poor prognosis in gastric carcinoma with low microsatellite instability
2003
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Hepatocellular carcinoma
2012 Standout
Prognosis prediction and staging
2014
A Molecular Signature to Discriminate Dysplastic Nodules From Early Hepatocellular Carcinoma in HCV Cirrhosis
2006
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
2012
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Diagnosis, management, and treatment of hepatitis C: An update # † ‡
2008 Standout
Nitric Oxide and Peroxynitrite in Health and Disease
2007 Standout
Helicobacter pylori Infection and the Development of Gastric Cancer
2001 Standout
Management of Hepatocellular Carcinoma: An Update Δσ
2011 Standout
Management of Hepatocellular Carcinoma *
2005 Standout
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases
2007 Standout
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Liver cancer: Approaching a personalized care
2015
Value of delayed hypointensity and delayed enhancing rim in magnetic resonance imaging diagnosis of small hepatocellular carcinoma in the cirrhotic liver
2010
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
2016
Intestinal and Diffuse Gastric Cancers Arise in a Different Background of Helicobacter pylori Gastritis Through Different Gene Involvement
1996
Chronic hepatitis B
2007 Standout
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
2016
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US
2015
Transarterial therapies for hepatocellular carcinoma
2011
Liver Transplantation in Cirrhotic Patients with Small Hepatocellular Carcinoma: An Analysis of Pre-Operative Imaging, Explant Histology and Prognostic Histologic Indicators
2004
Chronic hepatitis B: Update 2009 #
2009 Standout
Accuracy of Ultrasonography, Spiral CT, Magnetic Resonance, and Alpha-Fetoprotein in Diagnosing Hepatocellular Carcinoma: A Systematic Review. CME
2006
Loco‐regional treatment of hepatocellular carcinoma†
2010
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
Management of HCC
2012
Resection and Liver Transplantation for Hepatocellular Carcinoma
2005
Modified RECIST (mRECIST) Assessment for Hepatocellular Carcinoma
2010 Standout
Diagnosis and Treatment of Hepatocellular Carcinoma
2008
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
2014
Contrast-enhanced ultrasound in the diagnosis of hepatocellular carcinoma
2008
Treatment of intermediate-stage hepatocellular carcinoma
2014
Local-Regional Treatment of Hepatocellular Carcinoma
2011
Antimicrobial reactive oxygen and nitrogen species: concepts and controversies
2004 Standout
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
2009
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
2009
NF-κB functions as a tumour promoter in inflammation-associated cancer
2004 StandoutNature
Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Hepatocellular Carcinoma
2011 Standout
Treatment of Hepatocellular Carcinoma
2016
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies
2012
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging—A Systematic Review and Meta-Analysis
2015
Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma
2012
Suppression of Aβ-induced monocyte neurotoxicity by antiinflammatory compounds
1997
Evidence Supporting LI-RADS Major Features for CT- and MR Imaging–based Diagnosis of Hepatocellular Carcinoma: A Systematic Review
2017
Gadoxetic Acid-Enhanced Magnetic Resonance Imaging for Differentiating Small Hepatocellular Carcinomas (≤2 cm in Diameter) From Arterial Enhancing Pseudolesions
2010
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy
2016
Improved stability of lipiodol–drug emulsion for transarterial chemoembolisation of hepatocellular carcinoma results in improved pharmacokinetic profile: Proof of concept using idarubicin
2015
The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria
2009
Hepatocellular carcinoma
2022 Standout
Targeted Therapies for Hepatocellular Carcinoma
2011
Hepatocellular carcinoma: clinical frontiers and perspectives
2014
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Hepatocellular Carcinoma
2019 Standout
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
Hepatocellular Carcinoma Incidence, Mortality, and Survival Trends in the United States From 1975 to 2005
2009 Standout
Nitric oxide and the immune response
2001 Standout
Overall Survival After Transarterial Lipiodol Infusion Chemotherapy With or Without Embolization for Unresectable Hepatocellular Carcinoma: Propensity Score Analysis
2010
A Recombinant Hepatitis C Virus Genotype 1a E1/E2 Envelope Glycoprotein Vaccine Elicits Antibodies That Differentially Neutralize Closely Related 2a Strains through Interactions of the N-Terminal Hypervariable Region 1 of E2 with Scavenger Receptor B1
2019 StandoutNobel
Silk Embolic Material for Catheter‐Directed Endovascular Drug Delivery
2021
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade
2014 Standout
Transarterial Chemoembolization and Radioembolization
2014
Hepatocellular Carcinoma: Epidemiology and Molecular Carcinogenesis
2007 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Of Mice and Not Men: Differences between Mouse and Human Immunology
2004 Standout
EASL Recommendations on Treatment of Hepatitis C 2018
2018 Standout
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Reshaping de Novo Protein Switches into Bioresponsive Materials for Biomarker, Toxin, and Viral Detection
2022 StandoutNobel
Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment
2017 StandoutNobel
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
The Continuing Challenges of Leprosy
2006 Standout
Works of Marta Burrel being referenced
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
2012
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
Clinical decision making and research in hepatocellular carcinoma: Pivotal role of imaging techniques
2010
Inducible Nitric Oxide Synthase in Monocytes from Patients with Graves’ Disease
1996
MRI angiography is superior to helical CT for detection of HCC prior to liver transplantation: An explant correlation
2003
Chemoembolization of hepatocellular carcinoma with drug eluting beads: Efficacy and doxorubicin pharmacokinetics
2006
p53 gene mutations and protein nuclear accumulation are early events in intestinal type gastric cancer but late events in diffuse type.
1995
Mri Angiography Is Superior to Helical Ct for Detection of Hcc Prior to Liver Transplantation: An Explant Correlation
2003
Transcatheter Treatment of Hepatocellular Carcinoma with Doxorubicin-loaded DC Bead (DEBDOX): Technical Recommendations
2011